Sequential administration of PD-1 and Tim-3 blockade in combination with SA-GM-CSF-anchored vaccine treatment effectively improved the cytotoxic activity of CTLs and established tumor-specific T cell immunity. The gene discussed is CSF2; the disease is neoplasm.